Inscopix, Inc. - Company Research Report

Company Overview

• Name: Inscopix, Inc.

• Mission: Inscopix seeks to unlock human potential by developing advanced technologies and quantitative neural circuit-based approaches to understand the brain in health and to heal it in disease.

• Founded: In 2011

• Founders: Drs. Kunal Ghosh, Mark Schnitzer, and Abbas El Gamal

• Key People:

• Kunal Ghosh: Founder & CEO

• Michaela Mueller: Chief Financial Officer

• Jonathan Nassi: Senior Director of Translational Science

• Sarah MacNamee: Senior Director of Sales, Western Markets

• Shanna Resendez: Senior Director of Customer Excellence

• Shay Neufeld: Director of Data Products and Analytics

• Keh-Yi Hong: General Manager, Asia Pacific Commercial Operations

• Board Members: Abbas El Gamal, PhD (Co-founder & Director), Ann Miura-Ko, PhD, Matt Hershenson

• Strategic Advisors: Mark Schnitzer, PhD, Thomas R. Insel, MD, Michael Ehlers, MD, PhD, William R. Brody, MD, PhD

• Headquarters: Mountain View, California, USA

• Global Headquarters Address:

1212 Terra Bella Ave, Suite 200, Mountain View, CA 94043

• Number of Employees: No information is available.

• Revenue: Estimated to be approximately $20-25 million in FY 2022.

• Known For: Inscopix is known for its pioneering neural circuit approach to improve understanding of the brain and accelerate therapeutic development for neurological and psychiatric disorders using miniaturized microscopes, known as miniscopes.

Products

1. Miniscope Platforms

• nVue System: Enables imaging of two distinct brain signals, capturing high-quality behavior movies synchronized with in vivo data.

• nVoke System: Integrates in vivo cellular-resolution calcium imaging with simultaneous or sequential optogenetic manipulation.

• nVista System: For large-scale brain signals in vivo calcium imaging in freely behaving animals.

• Quartet System: For multi-region imaging, allowing simultaneous calcium imaging of multiple brain regions in freely behaving animals.

Key Features:

• Calcium Imaging: Enables observation of neural activity by detecting calcium ion movements within neurons, using genetically-encoded protein GCaMP.

• Optogenetics: Allows manipulation of neuronal activity using light-sensitive proteins.

• Multimodal Integration: Combines different technological methods for in-depth neuroscience research.

• Data Analysis: Software for easy processing and analysis of collected data.

2. Data Product - IDEAS Platform

• A cloud-based solution for organizing, analyzing, and sharing brain imaging data at scale.

• Simplifies data handling and processing with automated data management and visualization tools.

Recent Developments

• New Product Launch: nVision System for Synchronized Acquisition of Behavioral Movies with In Vivo Miniscope Data was launched, offering single-step synchronization between neural circuit imaging and behavior video recording.

• Acquisition: Inscopix was acquired by Bruker, enhancing the company's capacity as a technology leader for in-vivo brain functional imaging.

• Platform Expansion: IDEAS Platform expanded to include individual lab use, allowing academic researchers to enhance data management and sharing capabilities.

• Collaborations: Co-marketing collaboration with Noldus Information Technology for the nVision System to incorporate advanced behavioral video tracking software.

Conclusion

Inscopix, Inc. stands as a pivotal player in the neuroscience research community, providing powerful tools and platforms that empower groundbreaking discoveries and fuel the development of new therapeutics for neurological and psychiatric disorders. With its innovative products, strategic collaborations, and recent growth through acquisition, Inscopix continues to expand its influence and capabilities in the field of brain imaging and research.